Nanologica AB (publ)

NICA.ST · Health Technology · Biotechnology · SE

nanologica.com

About

Nanologica AB (publ) is a Swedish biotechnology company based in Sodertalje, specializing in the research and development of pharmaceutical products. The company focuses on developing nanoporous silica-based materials for applications in drug delivery and chromatography, particularly for improving the absorption of poorly water-soluble drugs through nanocarrier technology. Listed on the stock market in 2015, Nanologica operates within the Health Care sector with a niche expertise in pharmaceutical excipients and purification technologies.

Annual results

Reported figures, SEK · revenue up 50.0% in 2025

YearRevenueNet incomeNet marginFree cash flow
202521.0M-51.0M-242.9%—
202414.0M-65.0M-464.3%—
20231.0M-75.0M-7500.0%—
20221.0M-55.0M-5500.0%—
202112.0M-50.0M-416.7%—

NICA.ST in MarketPulse

The live chart with RSI and moving averages, the price, news, signals and price alerts for Nanologica AB (publ) are inside MarketPulse — currently in private beta.

Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.

Nanologica AB (publ) (NICA.ST) — company profile and financials · MarketPulse